Down-Regulation and Clinic-Pathological Correlation of SIK-1 and SIL-1-LNC in Non-Small Cell Lung Cancer Patients
Open Access
- 1 April 2023
- journal article
- research article
- Published by EpiSmart Science Vector Ltd in Asian Pacific Journal of Cancer Prevention
- Vol. 24 (4) , 1407-1411
Abstract
Background: Non-small-cell lung cancer (NSCLC) is currently the leading cause of mortality cancer. Introducing noninvasive approaches to diagnose NSCLC, especially at an early phase, might improve the disease’s prognosis. Long noncoding RNAs (lncRNAs), which are important regulators of the expression genes inside the cells, have been linked to a range of biological processes, such as cancer progression and metastasis, including NSCLC. The present work aims to determine the potential involvement of SIK-1-LNC and SIK-1 in NSCLC pathogenesis and the possible use of these molecules as novel biomarkers or therapeutic targets. Methods: In this work, the expression levels of SIK-1-LNC and SIK-1 in 50 pairs of NSCLC tumor and tumor marginal tissues were evaluated. So, after total RNA extraction and complementary DNA synthesis, the SIK-1-LNC and SIK-1 expression levels were evaluated by real-time PCR. In the study groups, clinical and pathological characteristics of the NSCLC patients were also examined. Results: Our findings showed that tumor samples had much lower levels of SIK-1 and SIK-1-LNC expression than tumor margin samples. SIK-1-LNC expression was correlated with SIK-1 levels in NSCLC samples. Interestingly, both stage and lymph node metastasis features of the tumor were associated significantly with SIK-1 and SIK-1-LNC expression levels. A ROC curve analysis indicated a biomarker index of 0.69 and 0.74 for SIK-1 and SIK-1-LNC, respectively. Conclusion: Collectively, our study emphasized the role of SIK-1-LNC and SIK-1 downregulation in NSCLC oncogenesis. Additionally, SIK-1 and SIK-1-LNC, particularly the latter, have shown remarkable potential to be utilized as new NSCLC biomarkers and therapeutic targets.Keywords
This publication has 31 references indexed in Scilit:
- SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancersMolecular Cancer, 2017
- Increased MALAT1 expression predicts poor prognosis in esophageal cancer patientsBiomedicine & Pharmacotherapy, 2016
- Risk factors for lung cancer worldwideEuropean Respiratory Journal, 2016
- Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activationJournal of Hepatology, 2016
- Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissuesInternational Journal of Molecular Medicine, 2016
- Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinomaMolecular Medicine Reports, 2016
- Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature reviewChinese Journal of Cancer, 2016
- miR-203 promotes proliferation, migration and invasion by degrading SIK1 in pancreatic cancerOncology Reports, 2015
- Salt-Inducible Kinase 1 (SIK1) Is Induced by Gastrin and Inhibits Migration of Gastric Adenocarcinoma CellsPLOS ONE, 2014
- Molecular Mechanisms of Long Noncoding RNAsMolecular Cell, 2011